NasdaqCM - Delayed Quote USD

Mangoceuticals, Inc. (MGRX)

2.0300
+0.0200
+(1.00%)
At close: June 13 at 4:00:01 PM EDT
1.9800
-0.05
(-2.46%)
After hours: June 13 at 7:44:19 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
511.0840
615.8730
731.4930
8.9390
Cost of Revenue
216.4540
235.9090
299.9920
4.0890
Gross Profit
294.6300
379.9640
431.5010
4.8500
Operating Expense
11,473.7280
9,073.4900
9,650.3910
1,996.4320
Operating Income
-11,179.0980
-8,693.5260
-9,218.8900
-1,991.5820
Net Non Operating Interest Income Expense
0
-13.7000
0
-6.4730
Other Income Expense
--
--
6.4730
--
Pretax Income
-11,179.0980
-8,707.2260
-9,212.4170
-1,998.0550
Tax Provision
0
0
0
0
Net Income Common Stockholders
-11,177.9550
-8,706.1450
-9,212.4170
-1,998.0550
Diluted NI Available to Com Stockholders
-11,177.9550
-8,706.1450
-9,212.4170
-1,998.0550
Basic EPS
-4.63
-4.84
-8.58
-1.96
Diluted EPS
-4.63
-4.84
-8.58
-1.96
Basic Average Shares
2,733.5730
1,978.9660
1,074.2020
1,021
Diluted Average Shares
2,733.5730
1,978.9660
1,074.2020
1,021
Total Operating Income as Reported
-10,457.5650
-7,971.9930
-9,218.8900
-1,991.5820
Total Expenses
11,690.1820
9,309.3990
9,950.3830
2,000.5210
Net Income from Continuing & Discontinued Operation
-11,177.9550
-8,706.1450
-9,212.4170
-1,998.0550
Normalized Income
-11,177.9550
-8,706.1450
-9,212.4170
-1,998.0550
Interest Expense
--
13.7000
0
6.4730
Net Interest Income
0
-13.7000
0
-6.4730
EBIT
-11,179.0980
-8,693.5260
-9,212.4170
-1,991.5820
EBITDA
-10,176.7880
-7,962.0570
-9,187.5280
-1,987.7190
Reconciled Cost of Revenue
216.4540
225.9730
275.1030
4.0890
Reconciled Depreciation
1,002.3100
731.4690
24.8890
3.8630
Net Income from Continuing Operation Net Minority Interest
-11,177.9550
-8,706.1450
-9,212.4170
-1,998.0550
Normalized EBITDA
-10,176.7880
-7,962.0570
-9,187.5280
-1,987.7190
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 3/21/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers